期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Ascl2和microRNA-200家族在结肠癌组织和癌旁组织中的定量表达及二者的相关性分析 被引量：4

Quantitative expression of Ascl2 and microRNA-200 in colorectal cancer and their peri-cancerous mucosa and their correlation
下载PDF
导出
摘要 目的探讨Ascl2与MicroRNA-200家族在结肠癌(colorectal cancer,CRC)组织及癌旁组织中的表达及二者的相关性。方法采用实时定量PCR检测50例结肠癌患者的结直肠癌组织及其癌旁组织中Ascl2与MicroRNA-200家族表达,用SPSS 18.0统计软件进行统计分析。结果 Ascl2在癌组织中的表达显著高于癌旁组织(P<0.01),除了MicroRNA-429在癌组织中的表达与癌旁组织相比无统计学差异(P=0.2139),MicroRNA-200家族成员在癌组织中的表达都显著低于癌旁组织(P<0.05);且Ascl2和MicroRNA-200家族成员在癌组织中表达都呈负相关(r<-0.5,P<0.05)。结论发现与正常结直肠黏膜组织相比,Ascl2在结直肠癌组织中表达增高,MicroRNA-200家族表达降低,它们在结直肠癌组织中的表达呈现负相关。 Objective To investigate the expression of Ascl2 and microRNA-200 family members in colorectal cancer and their peri-cancerous mucosa tissues and determine their correlations. Methods The expression of Ascl2 mRNA and microRNA-200 family members in 50 colorectal cancer samples and their pericancerous mucosa was detected by real time-PCR. Statistical analysis was performed by SPSS 18 statistical software. Results The mRNA expression level of Ascl2 was significantly higher in cancerous samples than the corresponding peri-cancerous mucosa（ P 〈 0. 01）,while the levels of microRNA-200 family members were significantly lower in cancerous samples than the peri-cancerous mucosa（ P 〈 0. 05）,except that no difference was found in microRNA-429 expression between the 2 tissue samples（ P = 0. 2139）. The expression level of Ascl2 was negatively correlated with those of microRNA-200 family members（ r 〈- 0. 5,P 〈 0. 05）.Conclusion The expression level of Ascl2 is increased,while those of microRNA-200 family members are decreased in colorectal cancer tissues when compared with the corresponding peri-cancerous tissues. And the expression levels are negatively correlated.
作者 李姗姗 钟小莉 尚阳阳 潘琼 叶钧 汪荣泉
机构地区 第三军医大学西南医院全军消化病研究所
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第23期2377-2379,共3页 Journal of Third Military Medical University
基金 国家自然科学基金(81200268 81201685)~~
关键词 结肠癌 Ascl2 MicroRNA-200家族 colon cancer； Ascl2； microRNA-200 family
分类号 R394.3 [医药卫生—医学遗传学] R730.23 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1van-der-Flier L G,van-Gijn M E,Hatzis P,et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate[J]. Cell,2009,136(5):903-912.
  • 2田音,朱蓉,汪荣泉.Ascl2表达抑制对结肠癌细胞上皮-间质转化的影响[J].解放军医学杂志,2013,38(4):292-296. 被引量：5
  • 3Jubb A M,Chalasani S,Frantz G D,et al. Achaete-scute like 2(ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia[J]. Oncogene,2006,25(24):3445-3457.
  • 4Jubb A M,Hoeflich K P,Haverty P M,et al. Ascl2 and 11p15.5 amplification in colorectal cancer[J]. Gut,2011,60(11):1606-1607.
  • 5Stange D E,Engel F,Longerich T,et al. Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain[J]. Gut,2010,59(9):1236-1244.
  • 6Hur K,Toiyama Y,Takahashi M,et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition(EMT) in human colorectal cancer metastasis[J]. Gut,2013,62(9):1315-1326.
  • 7Uhlmann S,Zhang J D,Schwager A,et al. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer[J]. Oncogene,2010,29(30):4297-4306.
  • 8Hung C S,Liu H H,Liu J J,et al. MicroRNA-200a and-200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers[J]. Ann Surg Oneol,2013,20(Suppl 3):S360-S368.
  • 9Elson-Schwab I,Lorentzen A,Marshall C J. MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion[J]. PLoS One,2010,5(10):e13176.
  • 10Grassian A R,Lin F,Barrett R,et al. Isocitrate dehydrogenase(IDH) mutations promote a reversible ZEB1/microRNA(miR)-200-dependent epithelial-mesenchymal transition(EMT)[J]. J Biol Chem,2012,287(50):42180-42194.

二级参考文献29

  • 1Greenburg G, Hay ED. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells[J].J Cell Biol, 1982, 95(1 ): 333-339.
  • 2Lee JM, Dedhar S, Kalluri R, et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease[J].J Cell Biol, 2006, 172(7): 973-981.
  • 3De Wever O, Pauwels P, De Craene B, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front[J]. Histochem Cell Biol, 2008, 130(3): 481-494.
  • 4van der Flier LG, van Gijn ME, Hatzis P, et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate[J]. Cell, 2009, 136(5): 903-912.
  • 5Jubb AM, Hoeflich KP, Haverty PM, et al. Ascl2 and 11p15.5 amplification in colorectal cancer [J]. Gut, 2011, 60( 11 ): 1606-1607.
  • 6van der Flier LG, van Gijin ME, Hatzis P, et al. Expression of an Ascl2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain[J]. Gut, 2010, 59(9): 1236-1244.
  • 7Jubb AM, Chalasani S, Frantz GD, et al. Achaete-scute like 2 (ascl2) is a target of Wnt signaling and upregulated in intestinal neoplasia[J]. Oncogene, 2006, 25(24): 3445-3457.
  • 8Zhu R, Yang Y, Tian Y, et al. Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells[J]. PLoS One, 2012, 7(2): e32170.
  • 9Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells[J]. Cell, 2008, 133(4): 704-715.
  • 10Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits[J]. Nat Rev Cancer, 2009, 9(4): 265-273.

共引文献7

同被引文献34

  • 1郭小毛,梅欣,朱国培,廖原.食管癌常规放疗与三维适形放疗比较及4种不同设野技术的剂量学研究[J].中国癌症杂志,2005,15(5):462-465. 被引量：35
  • 2Wouters B G,Weppler S A,Koritzinsky M,et al.Hypoxia as a target for combined modality treatments[J].Eur J Cancer,2002,38(2):240-257.
  • 3Xu R H,Pelicano H,Zhou Y,et al.Inhibition of glycolysis in cancer cells:a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia[J].Cancer Res,2005,65(2):613-621.
  • 4Fidler I J.The pathogenesis of cancer metastasis:the 'seed and soil' hypothesis revisited[J].Nat Rev Cancer,2003,3(6):453-458.
  • 5Christiansen J J,Rajasekaran A K.Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis[J].Cancer Res,2006,66(17):8319-8326.
  • 6Gao D,Vahdat L T,Wong S,et al.Microenvironmental regulation of epithelial-mesenchymal transitions in cancer[J].Cancer Res,2012,72(19):4883-4889.
  • 7Thiery J P.Epithelial-mesenchymal transitions in development and pathologies[J].Curr Opin Cell Biol,2003,15(6):740-746.
  • 8Yan W,Fu Y,Tian D,et al.PI3 kinase/Akt signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells[J].Biochem Biophys Res Commun,2009,382(3):631-636.DOI:10.1016/j.bbrc.2009.03.088.
  • 9Semenza G L.HIF-1 and tumor progression:pathophysiology and therapeutics[J].Trends Mol Med,2002,8(4 Suppl):S62-S67.
  • 10Zhu R,Yang Y,Tian Y,et al.Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells[J].PLoS One,2012,7(2):e32170.

引证文献4

二级引证文献12

第三军医大学学报
2014年 第23期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部